Press

Newsroom

ImpriMed Raises $8M to Commercialize AI-Driven Personalized Drug Response Prediction Service in Pet Cancer Market

GlobeNewswire
Learn More →

ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers

PR Underground
Learn More →

ImpriMed Raises $4M for Customized Cancer Treatments for Dogs

GlobeNewswire
Learn More →